Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy

Progression-free survival

From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months

Time frame: Time between diagnosis and progression or death - up to 100 weeks